Finance

Beta
Lists
SOHO:IDX
Soho Global Health Tbk PT
IDR 1,140.00
-10.94%
(-140.00) 1D
Jun 5, 4:00:05 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SOHO...
Open
IDR 1,280
High
IDR 1,280
Low
IDR 1,095
Mkt. cap
14.47T
Avg. vol.
159.92K
Volume
37.50K
Dividend
6.37%
Quarterly dividend
IDR 18
Ex-dividend date
Jun 2, 2026
P/E ratio
22.02
52-wk high
IDR 4,010
52-wk low
IDR 610
EPS
IDR 52
Shares outstanding
12.69B
No. of employees
2K
Open
IDR 1,280
High
IDR 1,280
Low
IDR 1,095
Mkt. cap
14.47T
Avg. vol.
159.92K
Volume
37.50K
Dividend
6.37%
Quarterly dividend
IDR 18
Ex-dividend date
Jun 2, 2026
P/E ratio
22.02
52-wk high
IDR 4,010
52-wk low
IDR 610
EPS
IDR 52
Shares outstanding
12.69B
No. of employees
2K
News stories
From sources across the web
About Soho Global Health Tbk PT
CEO-
Employees2.33K
Founded1946
Headquarters-
SectorPharmaceutical industry
Websitesohoglobalhealth.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.50T
2.76T
2.85T
2.64T
Cost of goods sold
2.09T
2.31T
2.36T
2.11T
Cost of revenue
2.09T
2.31T
2.36T
2.11T
Research and development expenses
5.67B
6.63B
6.12B
8.79B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
237.34B
239.75B
271.85B
283.09B
Operating expense
242.98B
254.65B
282.00B
291.98B
Total operating expenses
2.34T
2.57T
2.65T
2.40T
Operating income
162.18B
188.25B
207.87B
233.35B
Other non operating income
-
-
-
-
EBT including unusual items
198.80B
194.35B
208.56B
241.35B
EBT excluding unusual items
169.72B
194.28B
208.32B
240.65B
Income tax expense
41.68B
44.62B
48.34B
51.50B
Effective tax rate
20.97%
22.96%
23.18%
21.34%
Other operating expenses
-26.00M
8.27B
4.02B
95.00M
Net income
157.12B
149.73B
160.23B
189.86B
Net profit margin
6.29%
5.43%
5.61%
7.20%
Earnings per share
-
-
-
-
Interest and investment income
7.84B
6.38B
6.06B
5.04B
Interest expense
-264.00M
-
-178.00M
-145.00M
Net interest expenses
7.58B
6.38B
5.88B
4.90B
Depreciation and amortization charges
-
-
-
-
EBITDA
174.28B
200.53B
220.97B
246.64B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer